(Press-News.org) Ginseng has long been used in traditional medicine to replenish Qi and address deficiency syndromes, often manifesting as fatigue and immune compromise. Modern research is now elucidating the mechanisms behind these effects, focusing on ginseng’s immunomodulatory properties, ability to improve quality of life, and potential role in cancer therapy. This review aims to consolidate recent findings on these aspects, highlighting both the promises and limitations of ginseng as a scientifically supported therapeutic agent.
Immunomodulatory Effects of Ginseng
Ginseng’s immunomodulatory properties are primarily attributed to its active compounds, ginsenosides and polysaccharides. Ginsenosides Rg1 and Rb1 regulate cytokine production by inhibiting pro-inflammatory factors like TNF-α and IL-6 while promoting anti-inflammatory IL-10. This bidirectional modulation helps maintain immune homeostasis. Additionally, ginseng enhances natural killer (NK) cell activity via the TLR4/MyD88 pathway, increasing cytotoxicity by two- to threefold. Polysaccharides in ginseng, such as arabinogalactan, activate macrophage receptors and promote hematopoietic recovery, as evidenced by accelerated white blood cell regeneration in irradiated animal models.
Quality of Life Improvement
Ginseng significantly improves quality of life, particularly in individuals experiencing sub-health states—a condition characterized by chronic fatigue, cognitive decline, and emotional disturbances. A clinical study using Renshen Yuanqi (RSYQ) Drink, a ginseng extract, reported an 85% improvement in sub-health scores among young adults after 30 days. Key benefits included reduced fatigue, enhanced cognitive function, and improved mood. These effects align with ginseng’s traditional use in alleviating chronic fatigue and supporting mental well-being, likely mediated by ginsenosides with antidepressant and neuroprotective properties.
Antitumor Potential
While direct cytotoxic effects of ginseng on tumor cells are not fully established, ginsenosides show promise in inhibiting tumor growth and metastasis. For example, ginsenoside Rh2 suppresses the PI3K/AKT pathway in prostate cancer, reducing tumor proliferation and invasion. Other ginsenosides, such as Rg3 and Compound K, exhibit neuroprotective effects and ameliorate cancer-related fatigue by activating AMPK signaling. These mechanisms suggest ginseng’s potential as an adjunct therapy in oncology, though clinical evidence remains preliminary.
Safety Considerations
Despite its benefits, ginseng poses safety concerns, particularly at high doses or when combined with certain medications. Adverse effects include nervous system disturbances, gastrointestinal issues, and interactions with anticoagulants (e.g., warfarin) and beta-blockers (e.g., metoprolol). Ginsenosides may also inhibit liver enzymes like CYP3A4, potentiating drug toxicity. Concurrent use with other herbs, such as aconite, can lead to severe reactions. Therefore, careful dosing and monitoring are essential for safe integration into clinical practice.
Clinical Cases and Future Directions
A case study involving a 62-year-old female cancer patient demonstrated a significant reduction in sub-health scores after 30 days of RSYQ Drink intervention. Future research should focus on large-scale randomized controlled trials to validate these findings and explore ginseng’s synergistic effects with conventional therapies. Optimized assessment tools for sub-health and mechanistic studies on immunomodulation and antitumor pathways are also needed.
Conclusion
Ginseng and its extracts offer compelling benefits for immune support, quality of life enhancement, and potential antitumor applications. However, robust clinical evidence is still limited, and safety concerns necessitate cautious use. Future studies should prioritize high-quality trials to fully harness ginseng’s potential in integrative medicine.
Full text:
https://www.xiahepublishing.com/2835-6357/FIM-2025-00027
The study was recently published in the Future Integrative Medicine.
Future Integrative Medicine (FIM) is the official scientific journal of the Capital Medical University. It is a prominent new journal that promotes future innovation in medicine.It publishes both basic and clinical research, including but not limited to randomized controlled trials, intervention studies, cohort studies, observational studies, qualitative and mixed method studies, animal studies, and systematic reviews.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
Meningiomas are the most common primary brain tumors, accounting for nearly one-third of all central nervous system (CNS) tumors. While most are benign and manageable, 20–30% progress to high-grade forms that behave aggressively, recur frequently, and resist standard treatments. Recurrence remains a major clinical challenge, as these tumors often return stronger, leaving patients with limited therapeutic options. Despite advances in understanding their genetic and molecular profiles, how meningiomas evolve from primary to recurrent states has remained ...
People are exposed to millions of fungal spores every day, even potentially harmful ones like those from Aspergillus fumigatus. For most individuals, this constant exposure is harmless, as the immune system efficiently clears the spores without causing illness. However, for a growing number of people with weakened immune systems due to cancer, organ transplants, or chronic diseases, Aspergillus spores can lead to life-threatening infections known as aspergillosis. Thus, understanding the specific immune mechanisms that fight fungal infections is essential for developing therapies ...
In today’s world, people are increasingly prioritizing their health and well-being, with daily exercises and calorie-tracking apps becoming the new norm. People are therefore interested in incorporating highly nutritious food items such as fruits and vegetables into their diet plans. However, these foods—owing to contamination as well as due to certain cooking methods such as heating, smoking, grilling, roasting, and frying—may contain polycyclic aromatic hydrocarbons (PAHs) (hydrophobic organic compounds comprising ...
ROCHESTER, Minnesota — A new genetic test developed at Mayo Clinic is redefining how clinicians diagnose and manage hereditary pancreatitis. Pancreatitis, inflammation of the pancreas, is a complex condition that can lead to chronic pain, repeated hospitalizations and serious complications including diabetes, kidney failure and pancreatic cancer.
The new hereditary pancreatitis gene panel available through Mayo Clinic Laboratories (Mayo ID: PANGP) resulted from collaboration ...
Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in the peer-reviewed Journal of Clinical Psychiatry (JCP), a widely read and respected journal. The open-access article demonstrates that Mentavi’s asynchronous, online evaluation is as accurate as a traditional face-to-face clinical interview in the diagnosis of attention-deficit / hyperactivity disorder (ADHD) in adults and provides the first peer-reviewed evidence base for a fully digital ...
A zigzag stitch enables fabric to stretch until the thread is straight. University of Tartu researchers report in Advanced Materials that thread packing can encode fabric stretchability, leading the way to tailoring wearables at industrial scale.
As every body is unique, achieving a perfect dynamic fit of garments has to date relied on artisanal tailoring that cannot scale. Machine embroidery can place load-bearing thread in arbitrary patterns, but has been applied almost exclusively for visual appeal, such as logos and decorations. Embroidery machines ...
Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection (tearing) and death in childhood. Currently, there is no effective treatment or cure for MSMDS. A single error in the genetic code of the ACTA2 gene, which encodes the smooth muscle actin protein, is the most common cause of MSMDS. To directly target this mutation, researchers from Mass General Brigham engineered a bespoke CRISPR-Cas9 gene-editing enzyme to develop a potential therapy for ...
Johns Hopkins researchers have discovered new materials and a new process that could advance the ever-escalating quest to make smaller, faster and affordable microchips used across modern electronics—in everything from cellphones to cars, appliances to airplanes.
The team of scientists has discovered how to create circuits that are so small they’re invisible to the naked eye using a process that is both precise and economical for manufacturing.
The findings are published today in the journal Nature Chemical Engineering.
“Companies have their roadmaps ...
-With images-
Durham University scientists have completed one of the largest quality verification programmes ever carried out on superconducting materials, helping to ensure the success of the world’s biggest fusion energy experiment ITER.
Their findings, published in Superconductor Science and Technology, shed light not only on the quality of the wires themselves but also on how to best test them, providing crucial knowledge for scientists to make fusion energy a reality.
Fusion (the process that powers the Sun) has long been described as the holy grail of clean energy. It offers the promise of a virtually limitless power source with no carbon emissions ...
The latest survey from the European Centre for Disease Prevention and Control (ECDC), the fourth of its kind, confirms that Candidozyma auris (formerly Candida auris) continues to spread quickly across European hospitals, posing a serious threat to patients and healthcare systems. Case numbers are rising, outbreaks are growing in scale, and several countries report ongoing local transmission. The findings highlight the importance of early detection and control of transmission to avoid widespread rapid dissemination.
Candidozyma auris (C. auris) is a ...
